Seen on MRI as elevated apparent diffusion coefficient (ADC) (i.e. increased water diffusion).
Responds to dexamethasone therapy.
Cytotoxic oedema:
Increase in intracellular fluid in glia (particularly astrocytes) and neurons due to failure of cellular metabolism (ATP-dependent ion channels). Predominantly affects grey matter.
Commonest cause is early cerebral ischaemia (failure of oxygen delivery to brain tissue), for example stroke; near drowning; cardiac arrest; carbon monoxide poisoning.
Drugs and toxins, for example hepatic encephalopathy (secondary to elevated ammonia); isoniazid.
Seen on MRI as reduced ADC (decreased water diffusion).
Not helped by dexamethasone.
Interstitial oedema:
Secondary to obstructive hydrocephalus which causes transependymal bulk flow of CSF from ventricle into adjacent white matter.
Oedema predominantly affects periventricular white matter.
Remember: Vasogenic and not cytotoxic oedema is helped by dexamethasone therapy.
Prevention of normal skull growth (children):
Multisutural synostosis (premature fusion of skull sutures), for example Crouzon’s syndrome.
Pathology/Pathogenesis
Monro–Kellie doctrine:
Remember: The cranial compartment (the skull) is of a fixed volume. Any increase in volume of one of the intracranial contents (blood (intravascular or haematoma), CSF or brain tissue (oedema/tumour/abscess)) must be compensated by a decrease in another.
In normal circumstances, small increases in volume of contents are initially accommodated by the following:
A reduction in ventricular CSF-by (i) shifting it from the ventricles to the expandable spinal theca and (ii) increasing its absorption (which is pressure dependent).